mavii

News

Writing Strong Antibody Claims: Avoiding or Addressing USPTO Rejections for Written Description and Enablement

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement rejections under 35 U.S.C. §112(a). The USPTO routinely rejects claims as too broad.

IPWatchdog · 12d

New USPTO Group to Crack Down on Threats to U.S. Patent System

The U.S. Patent and Trademark Office (USPTO) on Wednesday announced a new working group dedicated to broadening the Office’s efforts to mitigate common threats to the U.S. patent system.

JD Supra · 13d

USPTO to Expedite Patent Issuance

The U.S. Patent and Trademark Office (USPTO) announced today that effective May 13, 2025, the time between an Issue Notification and issue date of

VoxelMatters · 11d

How USPTO is mitigating threats to the patent system

Explore the USPTO and patent system's role in protecting intellectual property and fostering innovation and economic growth.

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

SPC-14 was developed under a sponsored research agreement with Columbia University. In 2024, Silo entered into an exclusive global license agreement with Columbia University under which it is authorized to further develop, manufacture, and commercialize the drug SPC-14.

Yahoo Finance · 29d

Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

The USPTO Filing Receipt confirms that the patent application has been formally accepted and will proceed through the examination process. This development adds an important layer of protection as ...

Electronics Weekly · 12d

US to tackle patent abuse

Yesterday, the U.S. Patent and Trademark Office (USPTO) announced it is setting up the Patent Fraud Detection and Mitigation Working Group to mitigate

The Globe and Mail · 15d

Peraso Issued Notice of Allowance for New U.S. Patent Covering Seamless WLAN Access Point Recovery Technology

SAN JOSE, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a pioneer in mmWave wireless technology solutions, today announced it has received a Notice of Allowance from the U.

The Scientist · Jan 17, 2024

USPTO Issues Biotech Patent Guidelines

John J. Doll, director of biotechnology examination at USPTO, says the interim guidelines have become necessary to determine just how court decisions such as University of California Regents v. Eli Lilly and Co. will affect the patent application process.